All Stories

  1. Identification of novel variants in ten patients with Hermansky-Pudlak syndrome by high-throughput sequencing
  2. Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project
  3. Stanniocalcin 2 Regulates Non-capacitative Ca2+ Entry and Aggregation in Mouse Platelets
  4. Filamin A Modulates Store-Operated Ca2+Entry by Regulating STIM1 (Stromal Interaction Molecule 1)–Orai1 Association in Human PlateletsHighlights
  5. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders
  6. Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients
  7. Síndrome coronario agudo en pacientes con trombocitopenia. Respuesta
  8. Acute Coronary Syndrome in Patients With Thrombocytopenia. Response
  9. Bleeding risk of surgery and its prevention in patients with inherited platelet disorders
  10. Management of Primary Immune Thrombocytopenia With Eltrombopag in a Patient With Recent Acute Coronary Syndrome
  11. Tratamiento de trombocitopenia inmune primaria con eltrombopag en un paciente con síndrome coronario agudo reciente
  12. Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes
  13. Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency
  14. Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders
  15. Pharmacokinetics of a high-purity plasma-derived factor X concentrate in subjects with moderate or severe hereditary factor X deficiency
  16. Relationship between calcium mobilization and platelet α- and δ-granule secretion. A role for TRPC6 in thrombin-evoked δ-granule exocytosis
  17. Molecular and clinical profile of von Willebrand disease in Spain (PCM–EVW–ES): Proposal for a new diagnostic paradigm
  18. Role of mTOR1 and mTOR2 complexes in MEG-01 cell physiology
  19. Subcutaneous immunotherapy in hemophilic patients
  20. Sea-Blue Histiocytosis in Bone Marrow of a Patient with Chronic Thrombocytopenia
  21. C0429: Different Clinical Manifestation of Dysfibrinogenemias Associated to the Mutation Arg275 In Exon 8 of FGG Gene
  22. C0078: Relationship Between Extracellular and Intracelular Calcium Mobilization and Platelet Granule Secretion
  23. P-295 Azacytidine 75 mg/m2 ×5 day in high-risk myelodisplastic syndromes and acute myeloid leukemia refractory/relapsed patients
  24. P-074 Flow cytometric CD38 expression on CD34+ cells as a simple diagnostic test in myelodysplastic syndromes (MDS)
  25. Long-term mTOR inhibitors administration evokes altered calcium homeostasis and platelet dysfunction in kidney transplant patients
  26. Clinical and molecular characterization of Niemann–Pick types A/B patients
  27. Identification of seven novelSMPD1mutations causing Niemann-Pick disease types A and B
  28. C0358 Understanding recurrent thrombosis of antiphospholipid syndrome
  29. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry
  30. Homers regulate calcium entry and aggregation in human platelets: a role for Homers in the association between STIM1 and Orai1
  31. Allergenic vaccines administration and inhibitor development in haemophilia
  32. STIM1 tyrosine-phosphorylation is required for STIM1-Orai1 association in human platelets
  33. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
  34. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
  35. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
  36. The international factor IX treatment network survey
  37. 161 Azacytidine 75mg/m2 ×5 day in high-risk myelodysplastic syndromes and acute myeloid leukemia refractory/relapsed patients: Results from a single centre
  38. Prophylaxis therapy in haemophilia A: current situation in Spain
  39. The national registry of haemophilia A and B in Spain: results from a census of patients
  40. Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS